Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model. (Q53646650)

16 May 2018

title

Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model. (English)

1 reference

16 May 2018

author name string

Yu-Sheng Zhang

1

1 reference

16 May 2018

Ye Li

2

1 reference

16 May 2018

Yan Wang

3

1 reference

16 May 2018

Shi-Yue Sun

4

1 reference

16 May 2018

Tao Jiang

5

1 reference

16 May 2018

Cong Li

6

1 reference

16 May 2018

Shu-Xiang Cui

7

1 reference

16 May 2018

Xian-Jun Qu

8

1 reference

16 May 2018

publication date

24 December 2015

1 reference

16 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

16 May 2018

volume

142

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

913-925

1 reference

16 May 2018

Naringin ameliorates sodium arsenite-induced renal and hepatic toxicity in rats: decisive role of KIM-1, Caspase-3, TGF-β, and TNF-α.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case-control study in Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Biology of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Accumulation of phosphorylated beta-catenin enhances ROS-induced cell death in presenilin-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-κB and P53 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Regulation of inflammation in cancer by eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Cytokines, inflammation and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Chemopreventive sphingadienes downregulate Wnt signaling via a PP2A/Akt/GSK3β pathway in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Signal transducer and activator of transcription 3 (STAT3) protein suppresses adenoma-to-carcinoma transition in Apcmin/+ mice via regulation of Snail-1 (SNAI) protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Intestinal-specific PPARgamma deficiency enhances tumorigenesis in ApcMin/+ mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Kaiso overexpression promotes intestinal inflammation and potentiates intestinal tumorigenesis in Apc(Min/+) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Top-down morphogenesis of colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Modulation of Wnt/β-catenin signaling pathway by bioactive food components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Wnt signaling controls the phosphorylation status of beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC(Min/+) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-2097-9

Molecular pathology of colorectal cancer

21 January 2018

1 reference

12 December 2020

Naringin ameliorates cognitive deficits via oxidative stress, proinflammatory factors and the PPARγ signaling pathway in a type 2 diabetic rat model.

1 reference

12 December 2020

Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways

1 reference

12 December 2020

Berberis libanotica extract targets NF-κB/COX-2, PI3K/Akt and mitochondrial/caspase signalling to induce human erythroleukemia cell apoptosis

1 reference

12 December 2020

Naringin induces autophagy-mediated growth inhibition by downregulating the PI3K/Akt/mTOR cascade via activation of MAPK pathways in AGS cancer cells

1 reference

12 December 2020

Simultaneous separation and sensitive detection of naringin and naringenin in nanoparticles by chromatographic method indicating stability and photodegradation kinetics

1 reference

12 December 2020

Naringin Mitigates Cardiac Hypertrophy by Reducing Oxidative Stress and Inactivating c-Jun Nuclear Kinase-1 Protein in Type I Diabetes.

1 reference

12 December 2020

APC and its modifiers in colon cancer.

1 reference

12 December 2020

The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management.

1 reference

12 December 2020

10.1007/S00432-015-2097-9

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018